The effect of DAAs therapy for patients with HCV infection on prognosis and incidence of HCC
Not Applicable
Recruiting
- Conditions
- Patients with HCV infection
- Registration Number
- JPRN-UMIN000031091
- Lead Sponsor
- Graduate School of Medicine, Hokkaido University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with difficult-to-control heart disease 2)Other patients judged to be inappropriate to participate in the study by the primary physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method